EQUILLIUM, INC. (EQ) Pre-Tax Margin
- 2024-03-31: Pre-Tax Margin -25.58%.
- 2023-12-31: Pre-Tax Margin -25.25%.
- 2023-09-30: Pre-Tax Margin -36.23%.
- 2023-06-30: Pre-Tax Margin -36.55%.
Complete source-backed pre-tax margin history.
- Available history
- 2022-12-31 to 2024-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2024-03-31 | -25.58% |
| 2023-12-31 | -25.25% |
| 2023-09-30 | -36.23% |
| 2023-06-30 | -36.55% |
| 2023-03-31 | -43.70% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2024-12-31 | -18.75% |
| 2023-12-31 | -35.35% |
| 2022-12-31 | -396.14% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |